CACNA1A and Ataxia: In the sub‐analysis, participants with MSA‐C and those with SCA6 exhibited trends similar to the total participants with ataxia, with participants with MSA‐C showing a significant decrease in trajectory ratio and required time across trials (Figures S6 and S7).